ApoCell

Houston, United States Founded: 2004 • Age: 22 yrs Acquired By Precision Medicine Group
Provider of clinical trial and clinical development on bioanalytical services

About ApoCell

ApoCell is a Healthcare company based in Houston (United States) founded in 2004, and was acquired by Precision Medicine Group in October 2018. Provider of clinical trial and clinical development on bioanalytical services. The company has 2,198 employees. Its chief executive, as recorded, is Mark Clein. ApoCell offers products and services including Clinical Trial Management, Lab Services, and Biospecimens. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Bioanalytical Services. Its legal entity is Precision Medicine Group, LLC. Its competitors include BioAgilytix, Advion and Evans Analytical Group; 1 of its 3 listed competitors has raised funding.

Company details

ApoCell is a provider of tools for molecular profiling and diagnostics of tumor cells. It provides tools for molecular profiling and diagnostics for the biopharma industry and other translational medical groups. The company specializes in rare cell analysis, specifically in characterizing circulating tumor cells. It has developed ApoStream that distinguish CTCs from healthy blood cells through dielectrophoresis (DEP) and microfluidics. In addition, the company also provides services for functional biomarker analysis, single-cell protein analysis, and other traditional genomic analyses. ApoCell conducts sample analyses for clinical trials and also develops assays for the same.

Key Metrics

Products & Services of ApoCell

ApoCell offers a comprehensive portfolio of products and services, including Clinical Trial Management, Lab Services, and Biospecimens.

Clinical Trial Management
CRO Services

Manages trials for drug development in oncology.

Lab Services
Translational Sciences

Provides biomarker analysis and immune monitoring.

Biospecimens
Sample Management

Supplies tissues and fluids for research purposes.

Funding Insights of ApoCell

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of ApoCell with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2009Seed––
Valuation history

2 investors in total: 2 institutional.

Investors in ApoCell

ApoCell has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Precision Medicine Group and Summit Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Summit Partners is recognized as a growth equity investment firm.
summitpartners.comBoston, United States
Provider of clinical research, development, and commercialization services for life sciences
2012precisionmedicinegrp.comBethesda, United States
Premium access

Investor details for ApoCell

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of ApoCell

1 people are tracked at ApoCell (1 in leadership); the tracked headcount is 2,198.

NameRoleGroup
Mark Clein
CEOLeadership
Premium access

Complete people profiles for ApoCell

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of ApoCell

3 dated milestones of ApoCell across 14 years, from founding to its latest funding, stage changes and deals.

  1. Founded ApoCell is founded.
  2. Funding First funding round.
  3. Exit Acquired by Precision Medicine Group.

Competitors of ApoCell

ApoCell has 3 listed competitors in our database, 1 of them funded. They include BioAgilytix, Advion and Evans Analytical Group.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
bioagilytix.com2008Durham, United States446
Large-molecule bioanalysis is provided for biologics and biosimilars development.
advion.com1993Ithaca, United States$45.64M54
Microfluidics and mass spectrometry products are provided for clinical research.
eag.com1978San Diego, United States601
Company offering a suite of scientific services for materials, engineering, agri, and life science industries
Premium access

Detailed competitors of ApoCell

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as ApoCell (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Apocell

Premium access

Complete news archive for ApoCell

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ApoCell

ApoCell was founded in 2004 and raised its 1st funding round 5 years after it was founded.

ApoCell is headquartered in Houston, United States. It is registered at Houston, Texas, United States.

Mark Clein is the CEO of ApoCell, as recorded in our data.

ApoCell has 2,198 employees.

ApoCell is a provider of tools for molecular profiling and diagnostics of tumor cells. It provides tools for molecular profiling and diagnostics for the biopharma industry and other translational medical groups. The company specializes in rare cell analysis, specifically in characterizing circulating tumor cells. It has developed ApoStream that distinguish CTCs from healthy blood cells through dielectrophoresis (DEP) and microfluidics. In addition, the company also provides services for functional biomarker analysis, single-cell protein analysis, and other traditional genomic analyses. ApoCell conducts sample analyses for clinical trials and also develops assays for the same.

ApoCell's top competitors include BioAgilytix, Advion and Evans Analytical Group.

ApoCell offers Clinical Trial Management, Lab Services, and Biospecimens.

ApoCell has 2 investors. Key investors include Precision Medicine Group, and Summit Partners.

ApoCell operates through Precision Medicine Group, Llc.

Yes. ApoCell was acquired by Precision Medicine Group in October 2018.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available